# China NMPA Drug Inspection - Guangdong Bidi Pharmaceutical Co., Ltd. - Amoxicillin granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-bidi-pharmaceutical-co-ltd/905e318b-d7b1-40b4-aa79-7a42121b90f6/
Source feed: China

> China NMPA drug inspection for Guangdong Bidi Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Amoxicillin granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Guangdong Bidi Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin granules
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/guangdong-bidi-pharmaceutical-co-ltd/9e579f82-a219-49c9-ba98-ac135c1c6832/